Catechol-O-methyltransferase (COMT) degrades dopamine and its precursor L-DOPA and plays a critical role in regulating synaptic dopamine actions. We investigated the effects of heightened levels of COMT on dopamineregulated motor behaviors and molecular alterations in a mouse model of dyskinesia. Transgenic mice overexpressing human COMT (TG) and their wildtype (WT) littermates received unilateral 6-OHDA lesions in the dorsal striatum and were treated chronically with L-DOPA for two weeks. L-DOPA-induced dyskinesia was exacerbated in TG mice without altering L-DOPA motor efficacy as determined by contralateral rotations or motor coordination. Inductions of FosB and phospho-acetylated histone 3 (molecular correlates of dyskinesia) were potentiated in the lesioned striatum of TG mice compared with their WT littermates. The TG mice had lower basal levels of dopamine in the striatum. In mice with lesions, L-DOPA induces a greater increase in the dopamine metabolite 3-methoxytyramine in the lesioned striatum of dyskinetic TG mice than in WT mice. The levels of serotonin and its metabolite were similar in TG and WT mice. Our results demonstrate that human COMT overexpression confers a heightened susceptibility to L-DOPA-induced dyskinesia and alters molecular and neurochemical responses in the lesioned striatum of mice.
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Chronic use of the dopamine (DA) precursor L-3,4-dihydroxyphenylalanine (L-DOPA) for effective noninvasive treatment of Parkinson's disease (LeWitt, 2015) induces abnormal involuntary motor movements known as L-DOPA-induced dyskinesia (LID). In mice, these abnormal involuntary movements appear in the limbs as hyperkinetic and jerky stepping movements of the forelimbs or small circular movements of the forelimb to and from the snout. There are also axial (lateral flexion of the neck or torsional movements) and orolingual (bursts of masticatory movements from facial, jaw, and tongue muscles) areas (Pavón et al., 2006; Cenci and Lundblad, 2007) The enzymes that regulate DA concentrations may play a role in the development of LID (Marin and Obeso, 2010; Müller, 2015) . Catechol-O-methyltransferase (COMT) is encoded within the 22q11.2 chromosomal segment. It has been linked to LID. COMT catalyzes the O-methylation of catecholamines including DA and plays an important role in regulating the synaptic actions of DA and its precursor L-DOPA (Müller, 2015) . The role of COMT in dopamine (DA) metabolism in the striatum is less important than in other areas such as the frontal cortex and the hypothalamus (Gogos et al., 1998) . However, previous studies have demonstrated that L-DOPA treatment increases the expression and activity of COMT in the striatum (Zhao et al., 2001) . Clinical observations suggest that the impact of COMT in regulating LID is Neurobiology of Disease 102 (2017) 133-139 Abbreviations: BAC, bacterial artificial chromosome; COMT, catechol-Omethyltransferase; DA, dopamine; DOPAC, 3,4-dihydroxyphenylacetic acid; D1R, dopamine receptor 1; H3, histone 3; HPLC, high performance liquid chromatography; L-DOPA, L-3,4-dihydroxyphenylalanine; LID, L-DOPA-induced dyskinesia; pAcH3, phosphoacetyl-histone 3; TG, transgenic mice that carry a BAC comprising a 190-kb region of human chromosome 22q11.2 (BAC467.8); TH, tyrosine hydroxylase; WT, wild type; 3-MT, 3-methoxytyramine; 5-HT, serotonin; 5-HIAA, 5-hydroxyindoleacetic acid; 6-OHDA, 6-hydroxydopamine hydrobromide.
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